What is the relationship between laryngopharyngeal reflux and reflux esophagitis?October 13, 2008The association between gastroesophageal reflux disease (GERD) and laryngeal disorders has been recognized since the late 1960s. Chronic laryngeal signs and symptoms associated GERD are often referred to as reflux laryngitis or laryngopharyngeal reflux (LPR). However, the cause-and-effect relationship between GERD and LPR still remains elusive.. A research article to be published on July 28, 2008 in the World Journal of Gastroenterology addresses this question. The research team led by Dr. Yung-Chih Lai at Cathay General Hospital conducted the study to assess the prevalence rate of LPR in patients with reflux esophagitis and to disclose the factors contributing to the development of LPR. A total of 167 patients proved to have reflux esophagitis by endoscopy were enrolled. They would receive laryngoscopy to grade the reflux findings for the diagnosis of LPR. A validated questionnaire was used to identify the presence of laryngopharyngeal symptoms. A stringent criteria of inclusion was adopted to increase the specificity of laryngoscopic findings. The data of patients were then analyzed statistically to find out factors related to LPR. In their research, LPR was present and associated with reflux esophagitis. Age, hoarseness, and hiatus hernia were factors significantly associated with LPR. However, the development of LPR might be different from that of reflux esophagitis based on the findings of the study. The importance of hiatus hernia in LPR was revealed and deserves further study to elucidate in the future. World Journal of Gastroenterology |
|||||||||||||||||||||
| Related Reflux Esophagitis Current Events and Reflux Esophagitis News Articles Reflux esophagitis due to immune reaction, not acute acid burn, UT Southwestern researchers report Contrary to current thinking, a condition called gastroesophageal reflux disease (GERD) might not develop as a direct result of acidic digestive juices burning the esophagus, UT Southwestern Medical Center researchers have found in an animal study. Characteristic pathological findings in reflux esophagitis Recently, the number of patients with GERD has increased in Japan. However, there have been few reports about the pathological findings in the esophageal squamous epithelium, and there are differing opinions among pathologists about the findings considered characteristic of chronic reflux esophagitis. Chronic diarrhea unresponsive to conventional medication: Are you taking lansoprazole? Lansoprazole is a proton pump inhibitor which powerfully suppresses gastric acid production and is widely prescribed for chronic use in gastroesophageal reflux disease. Is esomeprazole the best choice for reflux esophagitis patients? In patients with gastroesophageal reflux disease (GERD), esomeprazole, has demonstrated pharmacological and clinical benefits beyond those seen with the other proton pump inhibitors( PPIs ). Alcohol types and socioeconomic status are associated with Barrett's esophagus risk Although the relationship between alcohol and esophageal squamous cell carcinoma is well established, studies investigating the association between alcohol intake and reflux esophagitis (RE), Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC) have reported inconsistent findings. Age, burden, divorce and heavy tea consumption are significant risk factors for erosive esophagitis Gastroesophageal reflux disease (GERD) is a common disorder with a high incidence rate in adults of 10 - 38%. The diagnosis and treatment of GERD are therefore important because the disease, in addition to the highly disturbing typical symptoms, has a series of known consequences. New Study on confirmatory Test Diagnosis for GastroEsophageal Reflux Disease 22 May 2001 - Mölndal, Sweden - The majority of patients presenting with chronic and frequent heartburn will be eventually diagnosed with gastroesophageal reflux disease (GERD). At present, the only means to confirm a suspected diagnosis, made by a physician following an analysis of symptom history, is endoscopy or pH monitoring, both expensive procedures often only available after a long wait. Currently, each year, endoscopic procedures cost US $ 22.6 million in Sweden alone.1 However, new data, presented today at the Digestive Diseases Week, Atlanta, USA suggests that patients presenting with chronic heartburn and free of alarm symptoms* could be prescribed a standard dose of esomeprazole More Reflux Esophagitis Current Events and Reflux Esophagitis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||